12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sun, 05 Apr 2026 22:18:01 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6InFjNlY5cFVoSTJWSW5cLzR2YVN4QkFRPT0iLCJ2YWx1ZSI6IjhuN0FcL1ZTVlcxWnhrZFd0WmRXazJxSkh6dVRVeitSWUFSSng0TFwvYzBoVHM2eVNcL3d6UUgweGcxbFwvZm1ZVFIzTU9ac1ZIVURxRThpaUxRTERuVDFPUT09IiwibWFjIjoiNzNlNzM0ZWRlOTVlNWIwNjJmOGNiMzFkNDkxNmMwNTQ0MDAwMjM4YzQyZGViZTFjNjQyYWZmZmY3N2RlZWYyMCJ9; expires=Wed, 04-Apr-2029 22:18:01 GMT; Max-Age=94608000; path=/; HttpOnly [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Mon, 06 Apr 2026 22:18:01 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=mnD7MgI2NB9WoBDv3TENH3LK1fjteN3nI9lppQSGbDtBTnddYR80%2BJUCxYl77kH5pOWS7cB5WxlksbpsZsbVa8xjmTzuIJxoHYQuBpbsds83Y4N36tAM%2BIimsn3pGG0x8JM%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [21] => Speculation-Rules: "/cdn-cgi/speculation" [22] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [23] => Server-Timing: cfEdge;dur=5,cfOrigin;dur=109 [24] => CF-RAY: 9e7bed204e48ce66-SIN [25] => alt-svc: h3=":443"; ma=86400 ) 789

中国研发的新型冠状病毒核酸检测试剂盒，已于28日通过中国国家药品监督管理局审批，获得医疗器械注册证书。

这个新测试剂盒宣称可在30分钟内获得结果，大幅缩短检测时间，可以让疫情疑似病例，尤其是没有病症的隐性感染者得到快速分流，有效防止疫情扩散。

这项产品由中国圣湘生物科技公司推出，中国体外检测诊断领域专家戴立忠主导的应急技术攻关小组研发，采用“RNA一步法”技术，适用于不同场景，操作简单，检测耗时短，再搭配圣湘生物自主研发的全自动核酸提取仪、移动分子诊断平台，能实现1人1机1日检测样本量达1000人份以上的高通量检测，最快可在30分钟出检测结果，实现现场即时检测。

---

// // // //